HNN3.0
Register
Register
Register

Project cooperationUpdated on 22 December 2025

AI-driven Telemedicine and Hypertension Research for Cardiovascular Health (Horizon Europe Partnerships)

Head of Sales at UAB Synergy Effect

Vilnius, Lithuania

About

Synergy Effect is a Lithuanian digital innovation and R&D company with more than 10 years of experience participating in national and European Union research and innovation programmes. We have strong expertise in Horizon Europe–related initiatives and applied research projects in healthcare and artificial intelligence

Our core focus in health research is cardiovascular disease prevention and management, with a particular emphasis on arterial hypertension. We have developed and clinically validated CardioCopilot, a remote hypertension monitoring and telemedicine platform (TRL6), implemented together with medical institutions and university cardiologists. The solution enables continuous blood pressure monitoring, patient engagement, risk detection and data-driven decision support for clinicians Hypertension. For partners.

We bring solid experience in:

  • Artificial intelligence and machine-learning solutions for health data processing and risk assessment

  • Telemedicine platforms and remote patient monitoring

  • Cardiovascular data analytics, interoperability and secure data pipelines

  • Applied research and collaboration with clinics, universities and public-sector partners

Synergy Effect is interested in joining international consortia as a technology and research partner in Horizon Europe and related EU programmes, particularly calls focused on:

  • Cardiovascular and heart-vascular disease research

  • Hypertension prevention, monitoring and management

  • AI-based analysis of health and clinical data

  • Multidisciplinary and cross-sectoral health innovation

We are especially interested in participating in Horizon Europe Destination calls, including:

  • HORIZON-HLTH-2026-01-DISEASE-11: Understanding sex and/or gender-specific mechanisms of cardiovascular diseases

  • HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health

We are open to long-term research cooperation, co-development of AI-based health solutions, and contribution to implementation research, data analytics and digital health innovation across Europe.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
  • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems

Type

  • Partner seeks Consortium/Coordinator

Organisation

UAB Synergy Effect

Company (SME)

Vilnius, Lithuania

Similar opportunities

  • Project cooperation

    Cardiovascular Digital Health Partner for Non-Invasive Vascular Monitoring

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Amin Hossein

    Researcher at Université Libre de Bruxelles

    Brussels, Belgium

  • Project cooperation

    Digital Health and Real-World Evidence for Advancing and Scaling Cardiovascular Innovation

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Konstantina Koutsiara

    Project Manager at VIDAVO S.A.

    Thessaloniki, Greece

  • Project cooperation

    Connected medical devices and real-world data to support sex and gender-specific cardiovascular research

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Celia Bengougam

    Medical Affairs Team Leader at Withings

    Paris, France